undefined
EUTM file information

018221626

KAPA EVOPLUS

April 5, 2020

Trademark Summary

The trademark application KAPA EVOPLUS was filed by Roche Diagnostics GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on April 21, 2020, and it was registered by office on July 30, 2020 without any oppositions.

It was designated 'Basic Application' for International Application 1631083 at the World Intellectual Property Organization (WIPO).

The application was filed in German (English was selected as the second language).

Change of name and address of the trademark registration was recorded on June 7, 2020.

Goods And Services

  • The mark was filed in class 1 with following description of goods:
    1. Chemical, biological and biochemical preparations for scientific purposes and for research purposes
    2. In vitro diagnostic reagents for use in research and science
    3. Chemical additives, enzymes, reagents, organisms and proteins for use in science, research and industry
    4. Chemical reagents for diagnostic tests and test kits for the determination of genetic information for scientific or research purposes
    5. Assays and reagents for use in genetic research
    6. Reagents and nucleotides for the sequencing of nucleic acids for scientific or research purposes.
  • The mark was filed in class 5 with following description of goods:
    1. In vitro diagnostic reagents for clinical or medical purposes
    2. In vitro diagnostics, namely, reagents and control solutions for the analysis of biological samples for medical diagnostic purposes
    3. Chemical reagents and test kits comprised of diagnostic reagents for medical diagnostic purposes in the field of DNA sequencing and genetics
    4. Diagnostic test kits consisting mainly of reagents for the determination and analysis of nucleic acids for medical use
    5. Reagents for medical diagnostic use and diagnostic kits comprised of medical diagnostic reagents and assays for use in connection with DNA sequencing and genetic analysis for medical purposes.
  • The mark was filed in class 42 with Research and development in the fields of genetic and protein engineering.